
An Odyssey in antiviral drug development-50 years at the Rega Institute: 1964-2014
Keywords: برومودین; Erik De Clercq; Antiviral drug; Poly(I)·poly(C); Polyacrylic acid; Interferon; Reverse transcriptase; Suramin; Valaciclovir; Brivudin; Stavudine; Tenofovir disoproxil fumarate (TDF); Truvada®; Atripla®; Complera®/Eviplera®; Stribild®; FV-100; Mozobi